Comprehensive Dermatologic Drug Therapy / Edition 2

Comprehensive Dermatologic Drug Therapy / Edition 2

by Stephen E Wolverton
     
 

ISBN-10: 1416033289

ISBN-13: 9781416033288

Pub. Date: 03/22/2007

Publisher: Elsevier Health Sciences

Safely and effectively prescribe today's full spectrum of topical, intralesional, and systemic drugs for dermatologic disorders! Dr. Steven E. Wolverton and a team of leading international experts explain what drugs to use, when to use them...and what to watch out for. Handheld software - included with the book - provides full-text explanations as well as

…  See more details below

Overview

Safely and effectively prescribe today's full spectrum of topical, intralesional, and systemic drugs for dermatologic disorders! Dr. Steven E. Wolverton and a team of leading international experts explain what drugs to use, when to use them...and what to watch out for. Handheld software - included with the book - provides full-text explanations as well as at-a-glance summaries of key pharmacologic information, instantly accessible wherever and whenever questions about skin pharmaceuticals arise.

• Provides at-a-glance access to key information including summaries of indications/contraindications, dosage guidelines, drug interactions, drug monitoring guidelines, adverse effects, and treatment protocols.
• Features a consistent organization throughout to expedite fast reference.
• Provides purchase information for major drugs, to help you and your patients.
• Includes a highly detailed, disease-specific index, helping you to evaluate drug options for each disease discussed.

• .Highlights key controversies and provides expert guidance in a Question and Answer feature.
• Presents new chapters on TNF Inhibitors, Signal II Cytokine Inhibitors, Pimicrolimus, IV Immunoglobulin, Drug-Induced Malignancies, Polymorphisms, and non-dermatologic drugs related to dermatologic problems.
• Features updates on new drug findings and new research, especially findings on predicting an individual response to drugs on the basis of ethnicity and gender.

Read More

Product Details

ISBN-13:
9781416033288
Publisher:
Elsevier Health Sciences
Publication date:
03/22/2007
Edition description:
REV
Pages:
1104
Product dimensions:
7.10(w) x 10.10(h) x 1.60(d)

Table of Contents

I. Introduction

1. Basic Principles of Pharmacology (Stephen E. Wolverton)
2. Principles for Maximizing the Safety of Dermatologic Drug Therapy (Stephen E. Wolverton)
3. Polymorphisms: Why Individual Drug Responses Vary (Benjamin N. Lockshin, Stephen E. Wolverton)

II. Systemic Drugs for Infectious Diseases

4. Systemic Antibacterial Agents (Neda Ashourian, Philip R. Cohen)
5. Systemic Antifungal Agents (Aditya K. Gupta )
6. Systemic Antiviral Agents (Y. Connie Chang, Vandana K. Madkan, Karan Sra, Daniel A. Carrasco, Patricia C. Lee, Stephen K. Tyring)

III. Systemic Immunomodulatory and Antiproliferative Drugs

7. Systemic Corticosteriods (Stephen E. Wolverton)
8. Methotrexate (Jeffrey P. Callen, Carol L. Kulp-Shorten, Stephen E. Wolverton)
9. Azathioprine (Stephanie Silos Badalamenti, Francisco A. Kerdel)
10. Cytotoxic Agents (Clifford Perlis, Teddy D. Pan, Charles J. McDonald)
11. Cyclosporine (Chai Sue Lee, John Y.M. Koo)
12.Dapsone (Russell P. Hall III, Clinzo P. Mickle)
13. Antimalarial Agents (Jeffrey P. Callen, Charles Camisa)
14. Systemic Retinoids (Timothy J. Patton, Matthew J. Zirwas, Stephen E. Wolverton)
15. Interferons (Brian Berman, Francisco Flores, Deborah Zel)

IV. Drugs Used in Conjunction with Ultraviolet or Visible Light

16. PUVA Photochemotherapy (Warwick L. Morison)
17. Extracorporeal Photochemotheraphy (Photopheresis) (Michael Girardi, Peter W. Heald)
18. Photodynamic Therapy (Robert Bissonnette, Jaggi Rao)

V. Biological Therapeutics

19. Tumor Necrosis Factor (TNF) Inhibitors (Stephanie Mehlis, Kenneth B. Gordon)
20. T-Cell Activation Inhibitors (Mark G. Lebwohl, Sapna Rao Palep)

VI. Miscellaneous Systemic Drugs

21. Antihistamines (Malcolm W. Greaves)
22. Vasoactive and Antiplatelet Agents (Seth B. Forman, Algin B. Garrett)
23. Antiandrogens and Androgen Inhibitors (Marty E. Sawaya)
24. Psychotropic Agents (Chai Sue Lee, John Y.M. Koo)
25. Intravenous Immunoglobulin Therapy (Kai Thomas, Anita Ruetter, Thomas A. Luger)
26. Miscellaneous Systemic Drugs (Alfred L. Knable Jr., Loretta S. Davis)
27. Drugs for the Skinternist (Michelle Pelle)

VII. Topical Drugs for Infectious Diseases

28. Topical Antibaterial Agents (Deborah J. Yang, Long T. Quan, Sylvia Hsu)
29. Topical Antifungal Agents (Rhea M. Phillips, Theodore Rosen)
30. Topical and Intralesional Antiviral Agents (Pranav B. Sheth)
31. Antiparasitic Agents (Benjamin N. Lockshin)

VIII. Topical Immunomodulatory and Antiproliferative Drugs

32. Topical Corticosteroids (Michael R. Warner, Charles Camisa)
33. Topical Retinoids (Naveed Sami, Julie C. Harper)
34. Topical and Intralesional Chemotherapeutic Agents (Eunice Y. Tsai, Herschel S. Zackheim, Youn H. Kim)
35. Topical Contact Allergens (Andrew N. Lin)
36. Topical Calcineurin Inhibitors (Andrew N. Lin)
37. Topical Vitamin D3 (Yolanda Rosi Helfrich, Dana L. Sachs, Sewon Kang)

IX. Miscellaneous Topical Drugs

38. Sunscreens (Stanley B. Levy)
39. Therapeutic Shampoos (Robert T. Brodell, Kevin D. Cooper)
40. Alpha-Hydroxy Acids (Amy B. Lewis, Helen Radoszycki)
41. Agents Used for Treatment of Hyperkeratosis (Adam B. Hessel, Julio C. Cruz-Ramon, Dana Marshall Klinger, Andrew N. Lin)
42. Cosmetic Therapy (Zoe Diana Draelos)
43. Miscellaneous Topical Agents (Seth B. Forman)
44. Insect Repellents (Mark S. Fradin)
45. Systemic Adverse Effects Due To Topical Medications (Peter J. Aronson)
46. Compounding in Dermatology (Linda F. McElhiney, Scott M. Ravis)

X. Injectable and Mucosal Routes of Drug Administration

47. Local Anesthetics (Michael J. Huether, David G. Brodland)
48. Botulinum Toxin Injections (Christian Murray, Nowell Solish)
49. Oral Mucosal Therapeutics (Ginat Wintermeyer Mirowski, Ernest Lee)

XI. Major Adverse Effects from Systemic Drugs

50. Hepatotoxicity of Dermatologic Drug Therapy (Stephen E. Wolverton)
51. Hematologic Toxicity of Dermatologic Drug Therapy (Kathleen A. Remlinger)
52. Drug Induced Malignancies (Stephen E. Wolverton)
53. Dermatologic Drugs During Pregnancy and Lactation (Barbara R. Reed)
54. Drug Interactions (Lori E. Shapiro, Neil H. Shear)
55. Cutaneous Drug Reactions with Systemic Features (Sandra R. Knowles, Neil H. Shear)

XII. Special Pharmacology and Therapeutic Topics

56. Pharmacoeconomics (Marc Alan Darst, Jennifer Reddan)
57. Informed Consent and Risk Management (Stephen E. Wolverton, Marshall B. Kapp )
58. FDA Drug Approval Process (William H. Eaglstein)
59. Pharmacovigilance: Verifying that Drugs Remain Safe (Joel M. Gelfand)
60. Dermatologic Drug Therapy in Children (Christopher M. Bohyer)

Index

Appendices

Read More

Customer Reviews

Average Review:

Write a Review

and post it to your social network

     

Most Helpful Customer Reviews

See all customer reviews >